UNC Cryo-EM Core Open House

Name: UNC Cryo-EM Core Open House
Start: 2026-10-19T14:00:00-0400
End: 2026-10-19T16:00:00-0400

Overview

Visit the UNC CryoEM Core to meet the director, tour the facility, and see our state-of-the-art instrumentation and advanced workflows in action. Learn about the services, training opportunities, and educational programs available through the Core. Discover how cryo-electron microscopy can support a wide range of life science research projects.

Whether you are new to cryoEM or exploring solutions for a current project, this is an opportunity to learn about UNC campus resources and discuss potential applications for your research with the UNC CryoEM Core team.

October 19, 2026 2:00pm - October 19, 2026 4:00pm

Glaxo Research Building, Room 008
101 Mason Farms Road
Chapel Hill, NC 27599

No Co

Biomanufacturing

October 15, 2026

FDA approves Priovant’s oral treatment for dermatomyositis

Durham-based Priovant Therapeutics has received U.S. Food and Drug Administration (FDA) approval for Lisraya (brepocitinib) 30 mg for the treatment of adults with dermatomyositis. Lisraya is a first-in-class TYK2/JAK1 inhibitor that is taken orally once a day.

December 4, 2026

Wake Forest Biomedical Graduate Programs Job & Internship Fair

The Wake Forest Biomedical Graduate Programs office will host its first annual Job & Internship Fair on December 4, bringing together our biomedical graduate students, postdoctoral trainees, and employers across life sciences sectors.

This event connects life sciences employers with students from 18 biomedical graduate programs. The student population includes Ph.D. and MS students with a broad mix of skill sets in basic and translational science, with an interest in advancing human health.

October 13, 2026

$40M UNC Lineberger center grant to support cancer vaccine development

With a new $40 million grant from the OpenAI Foundation, researchers at the UNC Lineberger Comprehensive Cancer Center will contribute to that effort by gathering data to train artificial intelligence models to identify stronger cancer-cell targets and help develop more precise and effective vaccines.